Crossmark

Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals

Crossref DOI link: https://doi.org/10.1186/s12891-018-2356-4

Published Online: 2018-12-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Korkosz, Mariusz

Czepiel, Marcin

Guła, Zofia

Stec, Małgorzata

Węglarczyk, Kazimierz

Rutkowska-Zapała, Magdalena

Gruca, Anna

Lenart, Marzena

Baran, Jarosław

Gąsowski, Jerzy

Błyszczuk, Przemysław

Siedlar, Maciej http://orcid.org/0000-0003-0540-5659
Funding

Funding for this research was provided by:

Narodowe Centrum Nauki (2013/09/B/NZ6/02545)

Uniwersytet Jagielloński Collegium Medicum (K/ZDS/006120)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 21 March 2018

Accepted: 22 November 2018

First Online: 6 December 2018

Ethics approval and consent to participate

: The study protocol was approved by the local bioethics committee (KBET/252/B/2012, Bioethics Committee of the Jagiellonian University, Podwale 3 Str., 31–118 Krakow, Poland). All included patients gave their informed written consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.